Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Zika virus premembrane protein (prM) is a viral structural protein that serves as a precursor to the mature membrane protein[1][2]. It plays a critical role in viral assembly, maturation, and infection by forming heterodimeric complexes with the envelope protein and protecting the fusion loop during transit through acidic intracellular compartments[1][2]. The prM protein stabilizes immature viral particles and is subsequently cleaved by the host protease furin to generate mature virions capable of cell-to-cell transmission[1][2]. Because prM is essential for multiple stages of the viral life cycle—including particle assembly, stabilization, and maturation—it represents a potential therapeutic target for Zika virus infection, though its fundamental role in viral replication means that inhibition strategies must be carefully designed to avoid resistance or unintended effects[2].
Inhibition of prM function could prevent proper viral particle assembly and maturation. Agents could stabilize the prM-E complex to prevent the conformational changes necessary for viral fusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zika virus premembrane protein (prM).